Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
fosfolipid 35 mg + protein 0,65 mg suspension |
Is a |
Lung surfactant preparation |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
Is a |
lungesurfaktant |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Surfaktant |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Protein |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phospholipid |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
Is a |
Product containing calfactant (medicinal product) |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Calfactant |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
Has manufactured dose form |
inhalationsdoseringsform |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
Has manufactured dose form |
Suspension for inhalation |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
Is a |
Product manufactured as pulmonary dose form (product) |
false |
Inferred relationship |
Some |
|
|
fosfolipid 35 mg + protein 0,65 mg suspension |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|